How has Médecins Sans Frontières contributed to the study of malaria medicines?
An analysis by the humanitarian medical aid organization Médecins Sans Frontières (MSF, Doctors without Borders) has found that between 1996 and 2004 MSF was responsible for about a quarter of all clinical studies of malaria medicine efficacy in 18 countries of Africa and Asia. In an article published in PLoS Medicine, Jean-Paul Guthmann (Epicentre, Paris, France) and colleagues report that MSF enrolled over 12,000 patients in 43 studies in these 18 countries during this time period. These 43 studies, say the authors, “provided extensive evidence on the efficacy of most drug regimens currently in use for uncomplicated malaria, which was often used for treatment policy changes by the concerned countries.” Guthmann and colleagues argue that MSF’s greatest contribution to studying the efficacy of malaria medicines was in conflict-affected countries of sub-Saharan Africa. In these countries MSF studies comprised the vast majority of available data and “traditional” academic research instit
Related Questions
- Does Médecins Sans Frontières organise events where I might be able to find out more information and talk to field workers?
- Skills in which foreign language(s) are most highly valued by Médecins Sans Frontières in recruiting for field missions?
- Can Doctors Without Borders/Médecins Sans Frontières (MSF) issue a receipt for donated goods or services?
